Literature DB >> 11964882

Invasive mycoses: management and unmet medical needs.

T F Patterson.   

Abstract

Mesh：

Year:  2001        PMID： 11964882     DOI： 10.1097/00001432-200112000-00001

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN： 0951-7375            Impact factor:   4.915


× No keyword cloud information.
  4 in total

1.  In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.

Authors:  F Sabatelli; R Patel; P A Mann; C A Mendrick; C C Norris; R Hare; D Loebenberg; T A Black; P M McNicholas
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs.

Authors:  J B Pfaller; S A Messer; R J Hollis; D J Diekema; M A Pfaller
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

3.  Economic evaluation of posaconazole versus standard azole therapy as prophylaxis against invasive fungal infections in patients with prolonged neutropenia in Canada.

Authors:  Amir A Tahami Monfared; Amy K O'Sullivan; Coleman Rotstein; George Papadopoulos
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

4.  Use of CHROMagar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited settings.

Authors:  Sayyada Ghufrana Nadeem; Shazia Tabassum Hakim; Shahana Urooj Kazmi
Journal:  Libyan J Med       Date:  2010-02-09       Impact factor: 1.657
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.